1126430-56-5 Usage
Uses
Used in Pharmaceutical Industry:
(R)-tert-Butyl 3-(5-nitropyridin-2-yloxy)pyrrolidine-1-carboxylate is used as a building block for the synthesis of various pharmaceuticals. Its structural diversity and compatibility with different chemical reactions make it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, (R)-tert-Butyl 3-(5-nitropyridin-2-yloxy)pyrrolidine-1-carboxylate is used as a key intermediate in the creation of agrochemicals. Its ability to be modified and incorporated into various chemical structures allows for the development of compounds with specific pesticidal or herbicidal properties.
Used in Drug Discovery and Development:
(R)-tert-Butyl 3-(5-nitropyridin-2-yloxy)pyrrolidine-1-carboxylate is used as a potential antagonist of certain biological receptors. Its interaction with these receptors can provide insights into the development of new therapeutic strategies for various diseases and conditions.
Used in Cancer Research:
(R)-tert-Butyl 3-(5-nitropyridin-2-yloxy)pyrrolidine-1-carboxylate has been studied for its moderate cytotoxic activity against certain cancer cell lines. This property makes it a candidate for further research and development as a potential anticancer agent.
Overall, (R)-tert-Butyl 3-(5-nitropyridin-2-yloxy)pyrrolidine-1-carboxylate is a versatile compound with a wide range of potential applications across different industries, particularly in the development of new therapeutics and biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1126430-56-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,6,4,3 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1126430-56:
(9*1)+(8*1)+(7*2)+(6*6)+(5*4)+(4*3)+(3*0)+(2*5)+(1*6)=115
115 % 10 = 5
So 1126430-56-5 is a valid CAS Registry Number.
1126430-56-5Relevant academic research and scientific papers
AMINO-SUBSTITUTED ISOTHIAZOLES
-
Page/Page column 195; 196, (2015/09/23)
The present invention relates to amino-substituted isothiazoles of general formula (I) : in which A, R1 and R2 are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.
THIAZOLE AND OXAZOLE KINASE INHIBITORS
-
Page/Page column 125, (2009/04/25)
The present invention provides thiazole and oxazole compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
